The University of Chicago Header Logo

Connection

Jeremy Segal to Cytarabine

Back to Details
This is a "connection" page, showing publications Jeremy Segal has written about Cytarabine.
Jeremy Segal
Connection Strength
0.042
Cytarabine
  1. A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. Blood Adv. 2020 02 25; 4(4):599-606.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.